NO960414L - Anvendelse av fenylcykloheksylkarboksylsyreamider - Google Patents

Anvendelse av fenylcykloheksylkarboksylsyreamider

Info

Publication number
NO960414L
NO960414L NO960414A NO960414A NO960414L NO 960414 L NO960414 L NO 960414L NO 960414 A NO960414 A NO 960414A NO 960414 A NO960414 A NO 960414A NO 960414 L NO960414 L NO 960414L
Authority
NO
Norway
Prior art keywords
acid amides
phenylcyclohexylcarboxylic
phenylcyclohexylcarboxylic acid
amides
acid
Prior art date
Application number
NO960414A
Other languages
English (en)
Other versions
NO309841B1 (no
NO960414D0 (no
Inventor
Matthias Muller-Gliemann
Ulrich Muller
Martin Beuck
Siegfried Zaiss
Christoph Gerdes
Anke Domdey-Bette
Rudi Grutzmann
Stefan Lohmer
Stefan Wohlfeil
Ozkan Yalkinoglu
James Elting
Dirk Denzer
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO960414D0 publication Critical patent/NO960414D0/no
Publication of NO960414L publication Critical patent/NO960414L/no
Publication of NO309841B1 publication Critical patent/NO309841B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO960414A 1995-02-01 1996-01-31 Anvendelse av et fenylcykloheksylkarboksylsyreamid, diastereomere fenylcykloheksylkarboksylsyreamider, fremgangsmÕte for fremstilling herav, legemiddel inneholdende diastereomerene og anvendelse av diastereomerene NO309841B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19503160A DE19503160A1 (de) 1995-02-01 1995-02-01 Verwendung von Phenylcyclohexylcarbonsäureamiden

Publications (3)

Publication Number Publication Date
NO960414D0 NO960414D0 (no) 1996-01-31
NO960414L true NO960414L (no) 1996-08-02
NO309841B1 NO309841B1 (no) 2001-04-09

Family

ID=7752849

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960414A NO309841B1 (no) 1995-02-01 1996-01-31 Anvendelse av et fenylcykloheksylkarboksylsyreamid, diastereomere fenylcykloheksylkarboksylsyreamider, fremgangsmÕte for fremstilling herav, legemiddel inneholdende diastereomerene og anvendelse av diastereomerene

Country Status (31)

Country Link
US (1) US5935983A (no)
EP (1) EP0725064A1 (no)
JP (1) JPH08253453A (no)
KR (1) KR960031442A (no)
CN (1) CN1137380A (no)
AR (1) AR002272A1 (no)
AU (1) AU710235B2 (no)
BG (2) BG103820A (no)
CA (1) CA2168317A1 (no)
CZ (1) CZ29196A3 (no)
DE (1) DE19503160A1 (no)
DZ (1) DZ1986A1 (no)
EE (1) EE9600023A (no)
FI (1) FI960425A (no)
HR (1) HRP960017A2 (no)
HU (1) HUP9600227A3 (no)
IL (1) IL116931A (no)
MA (1) MA23794A1 (no)
NO (1) NO309841B1 (no)
NZ (1) NZ280905A (no)
PL (1) PL312546A1 (no)
RO (1) RO117256B1 (no)
RU (1) RU2158261C2 (no)
SG (1) SG42329A1 (no)
SK (1) SK13796A3 (no)
SV (1) SV1996000008A (no)
TN (1) TNSN96016A1 (no)
TW (1) TW448176B (no)
UA (1) UA35623C2 (no)
YU (1) YU5896A (no)
ZA (1) ZA96725B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911462B2 (en) * 1998-05-22 2005-06-28 Avanir Pharmaceuticals Benzimidazole compounds for regulating IgE
DE19924818A1 (de) * 1999-05-29 2000-11-30 Bayer Ag Substituierte Phenylcyclohexancarbonsäureamide
DE19924819A1 (de) * 1999-05-29 2000-11-30 Bayer Ag Substituierte Phenylcyclohexancarbonsäurebenzylamid (Adenosinaufnahmeinhibitoren)
ATE369853T1 (de) * 2001-03-12 2007-09-15 Avanir Pharmaceuticals Benzimidazolderivate zur ige-modulierung und zellproliferationshemmung
DE10150310A1 (de) * 2001-10-11 2003-04-24 Bayer Ag Substituierte Piperazincyclohexancarbonsäureamide und ihre Verwendung
US6934951B2 (en) 2002-01-17 2005-08-23 Intel Corporation Parallel processor with functional pipeline providing programming engines by supporting multiple contexts and critical section
TW200304820A (en) * 2002-03-25 2003-10-16 Avanir Pharmaceuticals Use of benzimidazole analogs in the treatment of cell proliferation
TW200400040A (en) * 2002-05-17 2004-01-01 Wyeth Corp Hormone replacement therapy
TWI276631B (en) * 2002-09-12 2007-03-21 Avanir Pharmaceuticals Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
AU2003270426A1 (en) 2002-09-12 2004-04-30 Avanir Pharmaceuticals PHENYL-INDOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION
JP2007501618A (ja) * 2003-08-08 2007-02-01 アバニール・ファーマシューティカルズ タンパク質輸送の選択的薬理学的阻害、および関連した、ヒト疾患を治療する方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4226109A1 (de) * 1992-08-07 1994-02-10 Bayer Ag Verwendung von ASS zur Hemmung von Plaquebildung
DE4304455A1 (de) * 1993-02-15 1994-08-18 Bayer Ag Heterocyclisch substituierte Phenyl-cyclohexan-carbonsäurederivate
US5358959A (en) * 1993-02-18 1994-10-25 President And Fellows Of Harvard University Methods for treating arteriosclerosis
DE4401893A1 (de) * 1994-01-24 1995-07-27 Bayer Ag Substituierte Arylharnstoffe

Also Published As

Publication number Publication date
TNSN96016A1 (fr) 2005-03-15
SK13796A3 (en) 1996-10-02
HUP9600227A2 (en) 1996-12-30
CA2168317A1 (en) 1996-08-02
PL312546A1 (en) 1996-08-05
HRP960017A2 (en) 1997-12-31
NO309841B1 (no) 2001-04-09
EP0725064A1 (de) 1996-08-07
FI960425A0 (fi) 1996-01-30
SV1996000008A (es) 1996-11-04
BG103820A (bg) 2001-09-28
UA35623C2 (uk) 2001-04-16
DZ1986A1 (fr) 2002-10-15
TW448176B (en) 2001-08-01
US5935983A (en) 1999-08-10
SG42329A1 (en) 1997-08-15
AU4224096A (en) 1996-08-08
AR002272A1 (es) 1998-03-11
DE19503160A1 (de) 1996-08-08
NZ280905A (en) 1996-12-20
NO960414D0 (no) 1996-01-31
BG100326A (bg) 1996-08-30
BG63044B1 (bg) 2001-02-28
KR960031442A (ko) 1996-09-17
IL116931A (en) 2000-06-01
HU9600227D0 (en) 1996-03-28
IL116931A0 (en) 1996-05-14
ZA96725B (en) 1996-08-20
FI960425A (fi) 1996-08-02
YU5896A (sh) 1998-12-23
CN1137380A (zh) 1996-12-11
CZ29196A3 (en) 1996-08-14
JPH08253453A (ja) 1996-10-01
RU2158261C2 (ru) 2000-10-27
RO117256B1 (ro) 2001-12-28
HUP9600227A3 (en) 2000-03-28
AU710235B2 (en) 1999-09-16
MA23794A1 (fr) 1996-10-01
EE9600023A (et) 1996-08-15

Similar Documents

Publication Publication Date Title
BR9510256A (pt) Derivados de ácido 3-aril-tetrônico
LV11983A (lv) Iekskigi lietojams 2-metil-tieno-benzodiazepina zalu preparats
ATE211131T1 (de) Arylsulfonylaminohydroxamsäurederivate
BR9611130A (pt) Derivados de 3-aril-5-halógeno-pirona
BR9606814A (pt) Amidas de ácido alcoximinoacético
DE69606053D1 (de) Modifizierte fluorsulfonsäure
NO930760D0 (no) Substituerte fenyleddiksyreamider
FI960425A (fi) Fenyylisykloheksyylikarboksyylihappoamidien käyttö
NO930722L (no) Imidazolylsubstituerte fenyleddiksyreamider
NO940190D0 (no) Anvendelse av x-ketoglutarat
BR9607046A (pt) Derivados de 3-pirrolidiliden-2-ona-cefalosporinas
DE69605918D1 (de) Salpetersäure-hydrolyse von polyamiden
FI954422A0 (fi) Ferroseenin käyttö
NO980862L (no) Zwitterionformer av trovafloxacin
GB9525828D0 (en) Use of hetarylacetic acid derivatives
NO964685D0 (no) Isomering av equilin
FI953319A0 (fi) Dimetyylinaftaleenin valmistus
NO962385L (no) Terapeutiske amider
FI940309A (fi) 6-kloori-5-fluori-3-(2-tenoyyli)-2-oksindoli-1-karboksamidin lysiinisuola
DE69613921D1 (de) Herstellung von Methylaminen
TH30422B (th) เดลต้า-อะมิโน-แกมมา-ไฮดรอกซี-โอเมก้า-อะริล-อัลคาโนอิคแอซิดเอไมด์ชนิดใหม่
UA1112S (uk) Мікро-еом широкого призначення
FI940970A0 (fi) Neutralisering av saopa
KR970041939U (ko) 부품의 방진체결구조
KR960034358U (ko) 잭-판토그래프의 고정 구조

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JULY 2002